About Myomo
Myomo is a publicly listed company based in Boston (United States) founded in 2004. Robotic arms are provided for mobility and rehabilitation support. It operates in the Healthcare and Technology sectors. Myomo has raised $17.21 million across 12 funding rounds from investors including Children's Hospital of Philadelphia, Chicago Venture Partners and Empery Asset Management. The company has 185 employees. Its chief executive, as recorded, is Paul R Gudonis. Its website myomo.com draws about 21 thousand monthly visits. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Ekso Bionics, SuitX and Atom Limbs; 2 of its 3 listed competitors have raised funding.
Company details
Myomo was founded in 2004 and is headquartered in Boston, United States. Operations are centered in the medical device sector, where myoelectric prosthetic technology is developed for powered braces, or orthotics, that assist weakened extremities. Support is offered to individuals affected by neuromuscular conditions, including stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, and ALS.
- Annual Revenue$40.93 M (USD)25.73as on Dec 31, 2025
- Net Profit-$15.57 M (USD)-151.85as on Dec 31, 2025
- EBITDA-$12.64 M (USD)-132.74as on Dec 31, 2025
- Total Equity Funding$17.21M (USD)
in 12 rounds
- Latest Funding Round$3M (USD), Debt – Conventional
Oct 2019
- InvestorsChildren's Hospital of Philadelphia
& 4 more
- Employee Count185
Funding Insights of Myomo
Myomo has successfully raised a total of $17.21M across 12 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.21M
- Total Rounds 12
- Last Round Debt – Conventional — $3M
- First Round $375,000
(Jun 2006)
- Investors Count 5
Latest 10 of 12 funding rounds of Myomo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $3M | Debt – Conventional | – | – | |
| Feb 2019 | $6.4M | Post-IPO | – | – | – |
| Nov 2017 | Post-IPO | – | – | ||
| Jan 2017 | $50,000 | Grant | – | – | |
| Jul 2016 | $200,000 | Series B | – | – | – |
| Dec 2015 | $620,000 | Series B | – | – | – |
| May 2015 | $5M | Series B | – | – | |
| Apr 2014 | $199,953 | Grant | – | – | |
| Oct 2013 | $7M | Series B | – | Mountain Group Partners | – |
| Dec 2009 | $616,765 | Series A | – | – | – |
5 investors in total: 5 institutional.
Investors in Myomo
Myomo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Children's Hospital of Philadelphia, Chicago Venture Partners and Empery Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward US companies. | chicagoventure.com | Chicago, United States | ||
Venture capital is directed toward life sciences and technology sectors. | mtngp.com | Nashville, United States | ||
Manages a hedge fund with strategies focused on event-driven investments. | 2008 | emperyam.com | New York, United States | |
Chain of pediatrics hospitals | 1855 | chop.edu | United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Myomo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Myomo
54 people are tracked at Myomo (12 in leadership, 21 in board & advisors, 21 in team); the tracked headcount is 185.
| Name | Role | Group |
|---|---|---|
Paul R Gudonis | CEO | Leadership |
Joseph Chicoskie | Director of Marketing | Leadership |
Kathy Sawyers | Senior Director, Clinical Outcomes | Leadership |
Malcolm Bock | VP of Engineering & Product Strategy | Leadership |
Colin Anderson | Global Director of Operations | Leadership |
Harry Kovelman | Chief Medical Officer | Leadership |
David Henry | Chief Financial Officer | Leadership |
Micah Mitchell | Chief Commercial Officer | Leadership |
Andrew Harlan | Director Of Engineering | Leadership |
Nicole Lee | Director Of Patient And Market Access | Leadership |
Anya Manning | Director Of Product And Program Management | Leadership |
Joe Chicoskie | Director Of Marketing | Leadership |
Erica Borggren | Veteran Advisor | Board & advisors |
Coleman Nee | Chair, Veteran Advisory Board | Board & advisors |
Alexander Y. Shin | Veteran Advisor | Board & advisors |
Steven Kirshblum | Scientific Advisor | Board & advisors |
George F. Wittenberg | Scientific Advisor | Board & advisors |
Susan Duff | Scientific Advisor | Board & advisors |
Wayne Smith | Veteran Advisor | Board & advisors |
John Polanowicz | Veteran Advisor | Board & advisors |
34 more people are available in the full profile.
Complete people profiles for Myomo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Myomo
Myomo is a publicly listed company on the AMEX with ticker symbol MYO in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 May 2021
- Listed onFRA: 0M61
- Listed entityMyomo Inc.
- Exchange sectorDistribution services
- ISINUS62857J2015
- Share price$1.29 (-5.15% on the day) · 2026-10-13
- Market capitalisation$51.1M
- EPS (diluted, trailing year)$-0.34
- Volume (last session)341,865
Financials of Myomo
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $40.9M | -$15.6M | -$12.6M |
| 2024 | $32.5M | -$6.2M | -$5.4M |
| 2023 | $19.2M | -$8.2M | -$7.7M |
| 2022 | $15.6M | -$10.7M | -$10.1M |
| 2021 | $13.9M | -$10.4M | -$9.9M |
Detailed financial statements for Myomo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Myomo
4 dated milestones of Myomo across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Myomo is founded.
- Funding First funding round of $375K.
- Funding Latest funding round, Debt – Conventional, of $3.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Myomo
Myomo has 3 listed competitors in our database, 2 of them funded. They include Ekso Bionics, SuitX and Atom Limbs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eksobionics.com | 2005 | United States | $24.37M | 56 | Exoskeletons for medical rehabilitation and industrial productivity are provided. | |
| suitx.com | 2012 | Berkeley, United States | $5.13M | Lightweight exoskeletons are developed to assist walking for mobility-impaired users. | ||
| atomlimbs.com | 2019 | San Francisco, United States | AI-powered prosthetics restore physical abilities for users worldwide. |
Detailed competitors of Myomo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Myomo
The website of Myomo (myomo.com) receives about 21.2K visits a month and ranks #919,793 among all websites worldwide, #8,452 in Investing.
- Monthly visits21.2K
▼ 32% vs previous month
- Unique visitors16.1K
per month
- Global rank#919,793
among all websites
- Category rank#8,452
Finance · Investing
- Bounce rate50%
- Pages per visit2.0
- Average visit2 min 18 sec
- DevicesDesktop 23% · Mobile 77%
Top companies in Orthopedics
3 companies that operate in the same segment as Myomo (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Myomo
Complete news archive for Myomo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myomo
Myomo was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Myomo is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Paul R Gudonis is the CEO of Myomo, as recorded in our data.
Myomo is a funded company, having raised a total of $17.21M across 12 funding rounds to date. The company's 1st funding round was a Series A of $616.77K, raised on Jun 2006.
Myomo has 185 employees.
Annual revenue of Myomo is $40.93M as on Dec 31, 2025.
Myomo was founded in 2004 and is headquartered in Boston, United States. Operations are centered in the medical device sector, where myoelectric prosthetic technology is developed for powered braces, or orthotics, that assist weakened extremities. Support is offered to individuals affected by neuromuscular conditions, including stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, and ALS.
Myomo's top competitors include Ekso Bionics, SuitX and Atom Limbs.
Yes, Myomo is publicly traded on AMEX under the ticker symbol MYO.
Myomo has 5 investors. Key investors include Children's Hospital of Philadelphia, Chicago Venture Partners, Empery Asset Management, Mountain Group Partners, and National Science Foundation.